FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367048463> ?p ?o ?g. }

• W4367048463 endingPage "325285" @default.
• W4367048463 startingPage "fetalneonatal" @default.
• W4367048463 abstract "Objective To quantify the risks of mortality, morbidity and postnatal characteristics associated with extreme preterm fetal growth restriction (EP-FGR). Design The EVERREST (Do e s v ascular endothelial growth factor gene therapy saf e ly imp r ove outcome in seve r e e arly-onset fetal growth re st riction?) prospective multicentre study of women diagnosed with EP-FGR (singleton, estimated fetal weight (EFW) <3rd percentile, <600 g, 20 +0 –26 +6 weeks of gestation). The UK subgroup of EP-FGR infants (<36 weeks) were sex-matched and gestation-matched to appropriate for age (AGA) infants born in University College London Hospital (1:2 design, EFW 25th−75th percentile). Setting Four tertiary perinatal units (UK, Germany, Spain, Sweden). Main outcomes Antenatal and postnatal mortality, bronchopulmonary dysplasia (BPD), sepsis, surgically treated necrotising enterocolitis (NEC), treated retinopathy of prematurity (ROP). Results Of 135 mothers recruited with EP-FGR, 42 had a stillbirth or termination of pregnancy (31%) and 93 had live births (69%). Postnatal genetic abnormalities were identified in 7/93 (8%) live births. Mean gestational age at birth was 31.4 weeks (SD 4.6). 54 UK-born preterm EP-FGR infants (<36 weeks) were matched to AGA controls. EP-FGR was associated with increased BPD (43% vs 26%, OR 3.6, 95% CI 1.4 to 9.4, p=0.01), surgical NEC (6% vs 0%, p=0.036) and ROP treatment (11% vs 0%, p=0.001). Mortality was probably higher among FGR infants (9% vs 2%, OR 5.0, 95% CI 1.0 to 25.8, p=0.054). FGR infants more frequently received invasive ventilation (65% vs 50%, OR 2.6, 95% CI 1.1 to 6.1, p=0.03), took longer to achieve full feeds and had longer neonatal stays (median difference 6.1 days, 95% CI 3.8 to 8.9 and 19 days, 95% CI 9 to 30 days, respectively, p<0.0001). Conclusions Mortality following diagnosis of EP-FGR is high. Survivors experience increased neonatal morbidity compared with AGA preterm infants. Trial registration number NCT02097667 ." @default.
• W4367048463 created "2023-04-27" @default.
• W4367048463 creator A5001505718 @default.
• W4367048463 creator A5019394867 @default.
• W4367048463 creator A5026523394 @default.
• W4367048463 creator A5029350559 @default.
• W4367048463 creator A5034759025 @default.
• W4367048463 creator A5036632967 @default.
• W4367048463 creator A5037548205 @default.
• W4367048463 creator A5049802907 @default.
• W4367048463 creator A5055249823 @default.
• W4367048463 creator A5059002450 @default.
• W4367048463 creator A5060563692 @default.
• W4367048463 creator A5062898952 @default.
• W4367048463 creator A5063434649 @default.
• W4367048463 creator A5071822069 @default.
• W4367048463 creator A5086727967 @default.
• W4367048463 creator A5088083717 @default.
• W4367048463 creator A5091306660 @default.
• W4367048463 date "2023-04-26" @default.
• W4367048463 modified "2023-10-16" @default.
• W4367048463 title "Neonatal outcomes following early fetal growth restriction: a subgroup analysis of the EVERREST study" @default.
• W4367048463 cites W1757974377 @default.
• W4367048463 cites W1968532354 @default.
• W4367048463 cites W1970971784 @default.
• W4367048463 cites W1971675969 @default.
• W4367048463 cites W1979408634 @default.
• W4367048463 cites W1981360765 @default.
• W4367048463 cites W1987025848 @default.
• W4367048463 cites W1991328327 @default.
• W4367048463 cites W2020055572 @default.
• W4367048463 cites W2031964928 @default.
• W4367048463 cites W2038535763 @default.
• W4367048463 cites W2039503336 @default.
• W4367048463 cites W2122835085 @default.
• W4367048463 cites W2130427218 @default.
• W4367048463 cites W2152017985 @default.
• W4367048463 cites W2152650129 @default.
• W4367048463 cites W2301034803 @default.
• W4367048463 cites W2519262228 @default.
• W4367048463 cites W2580657348 @default.
• W4367048463 cites W2793805008 @default.
• W4367048463 cites W2913735792 @default.
• W4367048463 cites W2918047847 @default.
• W4367048463 cites W2965742712 @default.
• W4367048463 cites W4294116629 @default.
• W4367048463 cites W3092753896 @default.
• W4367048463 doi "https://doi.org/10.1136/archdischild-2022-325285" @default.
• W4367048463 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37185272" @default.
• W4367048463 hasPublicationYear "2023" @default.
• W4367048463 type Work @default.
• W4367048463 citedByCount "3" @default.
• W4367048463 countsByYear W43670484632023 @default.
• W4367048463 crossrefType "journal-article" @default.
• W4367048463 hasAuthorship W4367048463A5001505718 @default.
• W4367048463 hasAuthorship W4367048463A5019394867 @default.
• W4367048463 hasAuthorship W4367048463A5026523394 @default.
• W4367048463 hasAuthorship W4367048463A5029350559 @default.
• W4367048463 hasAuthorship W4367048463A5034759025 @default.
• W4367048463 hasAuthorship W4367048463A5036632967 @default.
• W4367048463 hasAuthorship W4367048463A5037548205 @default.
• W4367048463 hasAuthorship W4367048463A5049802907 @default.
• W4367048463 hasAuthorship W4367048463A5055249823 @default.
• W4367048463 hasAuthorship W4367048463A5059002450 @default.
• W4367048463 hasAuthorship W4367048463A5060563692 @default.
• W4367048463 hasAuthorship W4367048463A5062898952 @default.
• W4367048463 hasAuthorship W4367048463A5063434649 @default.
• W4367048463 hasAuthorship W4367048463A5071822069 @default.
• W4367048463 hasAuthorship W4367048463A5086727967 @default.
• W4367048463 hasAuthorship W4367048463A5088083717 @default.
• W4367048463 hasAuthorship W4367048463A5091306660 @default.
• W4367048463 hasBestOaLocation W43670484632 @default.
• W4367048463 hasConcept C126322002 @default.
• W4367048463 hasConcept C131872663 @default.
• W4367048463 hasConcept C172680121 @default.
• W4367048463 hasConcept C187212893 @default.
• W4367048463 hasConcept C187960798 @default.
• W4367048463 hasConcept C188816634 @default.
• W4367048463 hasConcept C2778376644 @default.
• W4367048463 hasConcept C2778384902 @default.
• W4367048463 hasConcept C2778721537 @default.
• W4367048463 hasConcept C2779234561 @default.
• W4367048463 hasConcept C2779303187 @default.
• W4367048463 hasConcept C2779918416 @default.
• W4367048463 hasConcept C44249647 @default.
• W4367048463 hasConcept C46973012 @default.
• W4367048463 hasConcept C54355233 @default.
• W4367048463 hasConcept C66322754 @default.
• W4367048463 hasConcept C71924100 @default.
• W4367048463 hasConcept C86803240 @default.
• W4367048463 hasConceptScore W4367048463C126322002 @default.
• W4367048463 hasConceptScore W4367048463C131872663 @default.
• W4367048463 hasConceptScore W4367048463C172680121 @default.
• W4367048463 hasConceptScore W4367048463C187212893 @default.
• W4367048463 hasConceptScore W4367048463C187960798 @default.
• W4367048463 hasConceptScore W4367048463C188816634 @default.
• W4367048463 hasConceptScore W4367048463C2778376644 @default.
• W4367048463 hasConceptScore W4367048463C2778384902 @default.

• next